As seen on:
As seen on:














Latest Articles
Looking to increase your dividend payout? Here are five stocks that can do the trick.
The Trump turmoil has pushed the share prices of these four stocks to their year lows. Could they be suitable for your portfolio?
Can SIA, SATS and SIA Engineering deliver higher dividends for investors? Read on to find out.
These five stocks have done well in the past year, but should they be in your investment portfolio?
Here are four REITs with distribution yields that should please an income investor.
Markets rebounded strongly last week, driven by earnings and major corporate news in Singapore and the US. We cover Keppel, Hongkong Land, Alphabet and more. Here’s what investors need to know.
Popular
With demand for AI set to grow over the long term, here are four Singapore REITs that can provide you with exposure to this booming sector.
Top Stock Market Highlights of the Week: Donald Trump’s Tariffs, CICT and Grab & Goto Merger
We look at the latest salvo fired by the new US President and a potential merger between two digital giants in Southeast Asia.
Trump 2.0 has arrived as growth in Generative AI continues.
These five stocks may be breaching their 52-week lows, but could they be a juicy bargain for investors who are looking for cheap stocks to scoop up?
Stocks
These five stocks’ share prices may have hit their year-low, but they could represent bargains waiting to be picked up.
Singapore investors are blessed with plenty of REIT options.
3 US Growth Stocks with Share Prices Punching Past Their 52-Week Highs: Are They a Compelling Buy?
These three stocks could be worthy of your attention.
These changes could signal more inflows and listings in due course.
Getting Started
We take a quick look at what this year has brought us.
As we head into a new year, here are five ways you can enhance your portfolio returns.
Will technology stocks remain relevant in the brave new world?
The world faces a different kind of problem aside from the pandemic, but one that can be tackled with pharmaceuticals.